| Lipid status at each visit . | ||||
|---|---|---|---|---|
| . | Not receiving antidiabetic medicine . | |||
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 3.0 mmol/L, n (%) | 52 (69.3%) | 50 (72.5%) | 36 (59.0%) | 28 (66.7%) |
| LDL cholesterol > 3.0 mmol/L, n (%) | 23 (30.7%) | 19 (27.5%) | 25 (41.0%) | 14 (33.3%) |
| Missing, n | 4 | 7 | 13 | 30 |
| Lipid status at each visit . | ||||
|---|---|---|---|---|
| . | Not receiving antidiabetic medicine . | |||
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 3.0 mmol/L, n (%) | 52 (69.3%) | 50 (72.5%) | 36 (59.0%) | 28 (66.7%) |
| LDL cholesterol > 3.0 mmol/L, n (%) | 23 (30.7%) | 19 (27.5%) | 25 (41.0%) | 14 (33.3%) |
| Missing, n | 4 | 7 | 13 | 30 |
| . | Receiving antidiabetic medicine . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 2.6 mmol/L, n (%) | 6 (85.7%) | 7 (87.5%) | 5 (50.0%) | 8 (80.0%) |
| LDL cholesterol > 2.6 mmol/L, n (%) | 1 (14.3%) | 1 (12.5%) | 5 (50.0%) | 2 (20.0%) |
| Missing, n | 0 | 2 | 2 | 4 |
| . | Receiving antidiabetic medicine . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 2.6 mmol/L, n (%) | 6 (85.7%) | 7 (87.5%) | 5 (50.0%) | 8 (80.0%) |
| LDL cholesterol > 2.6 mmol/L, n (%) | 1 (14.3%) | 1 (12.5%) | 5 (50.0%) | 2 (20.0%) |
| Missing, n | 0 | 2 | 2 | 4 |
| . | Summary . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| Normocholesterolemia, n (%) | 58 (70.7%) | 57 (74.0%) | 41 (57.7%) | 36 (69.2%) |
| Hypercholesterolemia, n (%) | 24 (29.3%) | 20 (26.0%) | 30 (42.3%) | 16 (30.8%) |
| Missing, n | 4 | 9 | 15 | 34 |
| . | Summary . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| Normocholesterolemia, n (%) | 58 (70.7%) | 57 (74.0%) | 41 (57.7%) | 36 (69.2%) |
| Hypercholesterolemia, n (%) | 24 (29.3%) | 20 (26.0%) | 30 (42.3%) | 16 (30.8%) |
| Missing, n | 4 | 9 | 15 | 34 |
Lipid status at visit 1 to 4. For women without diabetes, LDL cholesterol above 3.0 mmol/L is considered as hypercholesterolemia. For women with diabetes, LDL cholesterol above 2.6 mmol/L is considered as hypercholesterolemia. Cutoff limits were based on current clinical treatment guidelines.
Abbreviation: LDL, low-density lipoprotein.
| Lipid status at each visit . | ||||
|---|---|---|---|---|
| . | Not receiving antidiabetic medicine . | |||
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 3.0 mmol/L, n (%) | 52 (69.3%) | 50 (72.5%) | 36 (59.0%) | 28 (66.7%) |
| LDL cholesterol > 3.0 mmol/L, n (%) | 23 (30.7%) | 19 (27.5%) | 25 (41.0%) | 14 (33.3%) |
| Missing, n | 4 | 7 | 13 | 30 |
| Lipid status at each visit . | ||||
|---|---|---|---|---|
| . | Not receiving antidiabetic medicine . | |||
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 3.0 mmol/L, n (%) | 52 (69.3%) | 50 (72.5%) | 36 (59.0%) | 28 (66.7%) |
| LDL cholesterol > 3.0 mmol/L, n (%) | 23 (30.7%) | 19 (27.5%) | 25 (41.0%) | 14 (33.3%) |
| Missing, n | 4 | 7 | 13 | 30 |
| . | Receiving antidiabetic medicine . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 2.6 mmol/L, n (%) | 6 (85.7%) | 7 (87.5%) | 5 (50.0%) | 8 (80.0%) |
| LDL cholesterol > 2.6 mmol/L, n (%) | 1 (14.3%) | 1 (12.5%) | 5 (50.0%) | 2 (20.0%) |
| Missing, n | 0 | 2 | 2 | 4 |
| . | Receiving antidiabetic medicine . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| LDL cholesterol < 2.6 mmol/L, n (%) | 6 (85.7%) | 7 (87.5%) | 5 (50.0%) | 8 (80.0%) |
| LDL cholesterol > 2.6 mmol/L, n (%) | 1 (14.3%) | 1 (12.5%) | 5 (50.0%) | 2 (20.0%) |
| Missing, n | 0 | 2 | 2 | 4 |
| . | Summary . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| Normocholesterolemia, n (%) | 58 (70.7%) | 57 (74.0%) | 41 (57.7%) | 36 (69.2%) |
| Hypercholesterolemia, n (%) | 24 (29.3%) | 20 (26.0%) | 30 (42.3%) | 16 (30.8%) |
| Missing, n | 4 | 9 | 15 | 34 |
| . | Summary . | |||
|---|---|---|---|---|
| Visit . | 1 . | 2 . | 3 . | 4 . |
| Normocholesterolemia, n (%) | 58 (70.7%) | 57 (74.0%) | 41 (57.7%) | 36 (69.2%) |
| Hypercholesterolemia, n (%) | 24 (29.3%) | 20 (26.0%) | 30 (42.3%) | 16 (30.8%) |
| Missing, n | 4 | 9 | 15 | 34 |
Lipid status at visit 1 to 4. For women without diabetes, LDL cholesterol above 3.0 mmol/L is considered as hypercholesterolemia. For women with diabetes, LDL cholesterol above 2.6 mmol/L is considered as hypercholesterolemia. Cutoff limits were based on current clinical treatment guidelines.
Abbreviation: LDL, low-density lipoprotein.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
